Mendoza-Rodriguez et al. [48]
|
Female rat offspring
|
1.2 mg/kg BW/day
|
BPA diluted in drinking water
|
GD 6- D 21 of lactation
|
BPA offspring: irregular estrous cycles; significant increase in the thickness of uterine epithelium and stroma; modifications in apoptotic patterns of uterine epithelium and ERα downregulation
|
Newbold et al. [49]
|
Mice
|
0.1 (BPA 0.1), 1 (BPA 1), 10 (BPA10), 100 (BPA 100), 1000 (BPA 1000) μg/kg/day
|
Subcutaneous injections
|
GD 9-16
|
Adenomatous hyperplasia in BPA1 and BPA100 not in controls; atypical hyperplasia in BPA 0.1, BPA 1, BPA 1000 not in controls; endometrial polyps in BPA 0.1, BPA 1, BPA 10; stromal sarcoma in one BPA 100 mouse
|
Varayoud et al. [53]
|
Female rats
|
0.05 (BPA 0.5), 20 (BPA 20) mg/kg day
|
Subcutaneous injections
|
PND 1,3,5,7
|
Pregnancies were not established in 10% of BPA 0.5 and in 23% of BPA 20, whereas in the controls the pregnancy rate was 100%; decreased number of implantation sites in BPA20; lower ERα and PR expression; lower expression of Hoxa10
|
Bromer et al. [54]
|
Female mouse offspring
|
5 mg/kg
|
Intraperitoneal injections
|
GD 9-16
|
Hoxa10 increased expression; decreased DNA methylation in the promoter and in intron regions of Hoxa10 with consequent increase in binding of ER-α to Hoxa10 ERE
|
Xiao et al. [55] |
Pregnant mice |
0, 0.025, 0.5, 10, 40, 100 mg/kg/day |
Subcutaneous injections |
GD 0.5-3.5 |
No implantation sites in BPA 100 treated group; smaller implantation sites, increased gestation period, reduced postnatal survival rate in 40 BPA treated group; alterations in PR expression. |